Olivia C. Ware

Insider Reports History

Location
Los Angeles, CA
Signature
/s/ Peter Slover, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Olivia C. Ware:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23.5K 01 May 2024 Direct
Contineum Therapeutics, Inc. Director Stock Option (right to buy) 14.8K 26 Jun 2025 Direct
Arcellx, Inc. Director Stock Option (right to buy) 9.17K 29 May 2025 Direct

Insider Reports Filed by Olivia C. Ware

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTNM Contineum Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 26 Jun 2025, 17:41
ACLX Arcellx, Inc. 29 May 2025 1 $0 4 Director 30 May 2025, 16:14
RVNC Revance Therapeutics, Inc. 04 Feb 2025 2 -$60.9K 4 Director 06 Feb 2025, 15:56
ACLX Arcellx, Inc. 28 May 2024 1 $0 4 Director 06 Jun 2024, 16:18
CTNM Contineum Therapeutics, Inc. 24 May 2024 1 $0 4 Director 29 May 2024, 17:55
RVNC Revance Therapeutics, Inc. 01 May 2024 2 $0 4 Director 03 May 2024, 08:47
ACLX Arcellx, Inc. 16 Apr 2024 4 -$451K 4 Director 18 Apr 2024, 16:01
CTNM Contineum Therapeutics, Inc. 04 Apr 2024 0 $0 3 Director 04 Apr 2024, 17:59
ACLX Arcellx, Inc. 15 Mar 2024 5 -$565K 4 Director 18 Mar 2024, 18:38
ACLX Arcellx, Inc. 14 Jun 2023 1 $0 4 Director 16 Jun 2023, 16:23
RVNC Revance Therapeutics, Inc. 03 May 2023 2 $0 4 Director 05 May 2023, 17:15
ACLX Arcellx, Inc. 16 May 2022 1 $0 4 Director 17 May 2022, 17:14
ACLX Arcellx, Inc. 16 May 2022 0 $0 3 Director 17 May 2022, 17:12
RVNC Revance Therapeutics, Inc. 04 May 2022 1 $0 4/A Director 13 May 2022, 18:16
RVNC Revance Therapeutics, Inc. 05 May 2021 2 $0 4 Director 07 May 2021, 19:23